Valuation: Abbott Laboratories

Market Cap 20TCr 17TCr 16TCr 14TCr 27TCr 18,89700Cr 28TCr 1,87000Cr 73TCr 9,49300Cr 74TCr 73TCr 31,39900Cr P/E 2026 *
32.7x
P/E 2027 * 25.2x
Enterprise Value 22TCr 19TCr 18TCr 16TCr 30TCr 21,18800Cr 31TCr 2,09700Cr 82TCr 10,64400Cr 83TCr 81TCr 35,20400Cr EV / Sales 2026 *
4.4x
EV / Sales 2027 * 4x
Free-Float
86.16%
Yield 2026 *
2.25%
Yield 2027 * 2.4%
1 day-6.69%
1 week+12.73%
Current month+12.73%
1 month+11.71%
3 months+22.77%
6 months-8.15%
Current year-13.89%
1 week 105
Extreme 105
125.8
1 month 100
Extreme 100
125.8
Current year 90
Extreme 90
135
1 year 90
Extreme 90
144.1
3 years 90
Extreme 90
144.1
5 years 90
Extreme 90
144.1
10 years 90
Extreme 90
144.1
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-5.93%+12.73% - - 20TCr
+2.19%+4.83%-11.93%+12.47% 20TCr
+1.14%+3.06%+0.14%+14.51% 12TCr
+1.06%+2.59%+4.73%+76.30% 6.01TCr
-1.37%-6.27%+28.79%+60.98% 5.32TCr
+2.33%+5.51%-3.61%-29.85% 5.11TCr
+2.35%+0.94%+13.06%-12.93% 3.4TCr
+5.16%-3.71% - - 2.86TCr
-0.20%+2.00%+43.31%-8.95% 2.49TCr
+0.93%+0.79%-4.66%+6.28% 2.3TCr
Average +0.76%-0.37%+8.73%+14.85% 6.56TCr
Weighted average by Cap. -0.67%+0.83%+1.26%+17.72%

Financials

2026 *2027 *
Net sales 5.03TCr 4.31TCr 4.03TCr 3.69TCr 6.93TCr 4,81300Cr 7.02TCr 48TCr 19TCr 2,41800Cr 19TCr 18TCr 7,99700Cr 5.46TCr 4.68TCr 4.38TCr 4.01TCr 7.52TCr 5,22800Cr 7.62TCr 52TCr 20TCr 2,62600Cr 21TCr 20TCr 8,68700Cr
Net income 623.24Cr 533.86Cr 499.52Cr 457.26Cr 858.14Cr 60TCr 869.48Cr 5.9TCr 2.3TCr 30TCr 2.34TCr 2.29TCr 99TCr 792.44Cr 678.81Cr 635.14Cr 581.4Cr 1.09TCr 76TCr 1.11TCr 7.5TCr 2.93TCr 38TCr 2.98TCr 2.91TCr 1,26000Cr
Net Debt 2.39TCr 2.05TCr 1.92TCr 1.76TCr 3.3TCr 2,29000Cr 3.34TCr 23TCr 8.84TCr 1,15100Cr 8.99TCr 8.79TCr 3,80600Cr 2.1TCr 1.8TCr 1.68TCr 1.54TCr 2.89TCr 2,00500Cr 2.92TCr 20TCr 7.74TCr 1,00700Cr 7.87TCr 7.7TCr 3,33200Cr
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
1,15,000
Date Price Change Volume
19/26/19 $124.00 -1.43% 5
21/26/21 $113.70 +3.36% 3
20/26/20 $110.00 -11.29% 12
19/26/19 $124.00 -1.43% 5
18/26/18 $125.80 +19.81% 1
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
116.64USD
Average target price
120.20USD
Spread / Average Target
+3.05%

Quarterly revenue - Rate of surprise